BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1657575)

  • 21. Glucocorticoid inhibition of mineralocorticoid action in the rat.
    Kenyon CJ; Saccoccio NA; Morris DJ
    Clin Sci (Lond); 1984 Sep; 67(3):329-35. PubMed ID: 6380888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct and indirect effects of carbenoxolone on responses to glucocorticoids and noradrenaline in rat aorta.
    Walker BR; Sang KS; Williams BC; Edwards CR
    J Hypertens; 1994 Jan; 12(1):33-9. PubMed ID: 8157942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The amygdala: site of genomic and nongenomic arousal of aldosterone-induced sodium intake.
    Sakai RR; McEwen BS; Fluharty SJ; Ma LY
    Kidney Int; 2000 Apr; 57(4):1337-45. PubMed ID: 10760064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of aldosterone-induced antinatriuresis and kaliuresis by actinomycin D.
    Horisberger JD; Diezi J
    Am J Physiol; 1984 Feb; 246(2 Pt 2):F201-4. PubMed ID: 6696121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of RU28318 and RU40555 as selective mineralocorticoid receptor and glucocorticoid receptor antagonists, respectively: receptor measures and functional studies.
    Kim PJ; Cole MA; Kalman BA; Spencer RL
    J Steroid Biochem Mol Biol; 1998 Nov; 67(3):213-22. PubMed ID: 9879980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are we missing a mineralocorticoid in teleost fish? Effects of cortisol, deoxycorticosterone and aldosterone on osmoregulation, gill Na+,K+ -ATPase activity and isoform mRNA levels in Atlantic salmon.
    McCormick SD; Regish A; O'Dea MF; Shrimpton JM
    Gen Comp Endocrinol; 2008 May; 157(1):35-40. PubMed ID: 18462736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroidogenesis vs. steroid uptake in the heart: do corticosteroids mediate effects via cardiac mineralocorticoid receptors?
    Chai W; Hofland J; Jansen PM; Garrelds IM; de Vries R; van den Bogaerdt AJ; Feelders RA; de Jong FH; Danser AH
    J Hypertens; 2010 May; 28(5):1044-53. PubMed ID: 20179635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
    Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y
    Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.
    Ratka A; Sutanto W; Bloemers M; de Kloet ER
    Neuroendocrinology; 1989 Aug; 50(2):117-23. PubMed ID: 2550833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aldosterone effects on salt appetite in adrenalectomized rats.
    McEwen BS; Lambdin LT; Rainbow TC; De Nicola AF
    Neuroendocrinology; 1986; 43(1):38-43. PubMed ID: 3713988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The acute anticonvulsant effects of deoxycorticosterone in developing rats: role of metabolites and mineralocorticoid-receptor responses.
    Edwards HE; Vimal S; Burnham WM
    Epilepsia; 2005 Dec; 46(12):1888-97. PubMed ID: 16393154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
    van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
    Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors.
    Oitzl MS; Fluttert M; de Kloet ER
    Eur J Neurosci; 1994 Jul; 6(7):1072-9. PubMed ID: 7952288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
    Rickard AJ; Funder JW; Morgan J; Fuller PJ; Young MJ
    Endocrinology; 2007 Oct; 148(10):4829-35. PubMed ID: 17640982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 11 beta-OHSD inhibitor, carbenoxolone, enhances Na retention by aldosterone and 11-deoxycorticosterone.
    Morris DJ; Souness GW
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F756-9. PubMed ID: 2316675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central mineralocorticoid receptor antagonism blocks hypertension in Dahl S/JR rats.
    Gomez-Sanchez EP; Fort C; Thwaites D
    Am J Physiol; 1992 Jan; 262(1 Pt 1):E96-9. PubMed ID: 1310219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mineralocorticoid receptor-mediated changes in membrane properties of rat CA1 pyramidal neurons in vitro.
    Joƫls M; de Kloet ER
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4495-8. PubMed ID: 2162044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenal steroid receptors in the PVN: studies with steroid antagonists in relation to macronutrient intake.
    Tempel DL; McEwen BS; Leibowitz SF
    Neuroendocrinology; 1993 Jun; 57(6):1106-13. PubMed ID: 8232767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mineralocorticoids, hypertension, and cardiac fibrosis.
    Young M; Fullerton M; Dilley R; Funder J
    J Clin Invest; 1994 Jun; 93(6):2578-83. PubMed ID: 8200995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of glucocorticoid in the development of glycyrrhizin-induced hypertension.
    Kageyama Y; Suzuki H; Saruta T
    Clin Exp Hypertens; 1994 Nov; 16(6):761-78. PubMed ID: 7858558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.